Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Grass Pollen Allergy Pipeline Report, H2 2017 - Therapeutics Review of 4 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 28 Aug 17

The "Grass Pollen Allergy - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Grass Pollen Allergy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Grass Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 1, 1, 3 and 2 respectively.

Grass Pollen Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Grass Pollen Allergy - Overview
  3. Grass Pollen Allergy - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Products under Development by Companies
  7. Grass Pollen Allergy - Therapeutics Assessment
  8. Assessment by Route of Administration
  9. Assessment by Molecule Type
  10. Grass Pollen Allergy - Companies Involved in Therapeutics Development
  • ALK-Abello A/S
  • Allergy Therapeutics Plc
  • Biomay AG
  • HAL Allergy BV

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.